Tango Therapeutics (TNGX)
(Delayed Data from NSDQ)
$11.57 USD
+0.55 (4.99%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $11.57 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.24 |
Last EPS Surprise | 29.41% |
ABR | 1.00 |
Earnings ESP
|
1.04% |
---|---|
Current Year | -1.31 |
Next Year | -1.42 |
EPS (TTM) | -1.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.18M | 7.40M | 38.43M | 33.94M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 12.20M | 15.70M | 54.30M | 57.70M |
Low Estimate | 4.80M | 4.50M | 21.00M | 25.00M |
Year ago Sales | 10.73M | 5.43M | 36.53M | 38.43M |
Year over Year Growth Est. | -33.13% | 36.28% | 5.22% | -11.69% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.35 | -1.31 | -1.42 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.36 | -0.37 | -1.30 | -1.61 |
High Estimate | -0.30 | -0.26 | -1.13 | -1.01 |
Low Estimate | -0.38 | -0.42 | -1.52 | -1.61 |
Year ago EPS | -0.23 | -0.32 | -1.08 | -1.31 |
Year over Year Growth Est. | -52.17% | -9.38% | -21.30% | -8.62% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 3 | 2 |
Up Last 60 Days | 1 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 3 | 2 | 3 |
Down Last 60 Days | 4 | 3 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.35 | -1.31 | -1.42 |
7 Days Ago | -0.35 | -0.35 | -1.31 | -1.42 |
30 Days Ago | -0.34 | -0.32 | -1.33 | -1.39 |
60 Days Ago | -0.33 | -0.31 | -1.31 | -1.35 |
90 Days Ago | -0.32 | -0.30 | -1.28 | -1.28 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.33 | -1.27 | -1.41 |
Zacks Consensus Estimate | -0.35 | -0.35 | -1.31 | -1.42 |
Earnings ESP | 1.04% | 4.35% | 2.71% | 0.99% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.24 | -0.35 | -0.32 | -0.23 | NA |
Estimate | -0.34 | -0.31 | -0.28 | -0.34 | NA |
Difference | 0.10 | -0.04 | -0.04 | 0.11 | 0.03 |
Surprise | 29.41% | -12.90% | -14.29% | 32.35% | 8.64% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more